On September 7, 2026, the World Congress on Nuclear Medicine and Biology opened in Chile. The international scientific forum brings together physicians, radiology specialists, physicists, and radiopharmaceutical developers from around the world.

Discussions during the congress focus on critical areas of modern medicine, placing primary emphasis on the early detection of oncological diseases, the development of novel radiopharmaceuticals, and the widespread integration of molecular imaging technologies into clinical practice.

Participants presented recent scientific achievements in nuclear medicine, evaluated the capabilities of modern diagnostic equipment, and reviewed clinical outcomes. Furthermore, the event facilitates experience sharing among international researchers and fosters new avenues for scientific collaboration.

The congress serves as a vital platform for advancing international scientific cooperation, implementing cutting-edge diagnostic methodologies, and shaping the future trajectory of nuclear medicine.